These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17477109)

  • 21. Evolving understanding of the renin-angiotensin-aldosterone system: pathophysiology and targets for therapeutic intervention.
    Gradman AH
    Am Heart J; 2009 Jun; 157(6 Suppl):S1-6. PubMed ID: 19450719
    [No Abstract]   [Full Text] [Related]  

  • 22. The impact of left ventricular assist device-induced left ventricular unloading on the myocardial renin-angiotensin-aldosterone system: therapeutic consequences?
    Klotz S; Burkhoff D; Garrelds IM; Boomsma F; Danser AH
    Eur Heart J; 2009 Apr; 30(7):805-12. PubMed ID: 19223317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renin-angiotensin-aldosterone activation in heart failure, aldosterone escape.
    Andrew P
    Chest; 2002 Aug; 122(2):755. PubMed ID: 12171868
    [No Abstract]   [Full Text] [Related]  

  • 24. [Congestive heart failure].
    Nagasaka M
    Nihon Rinsho; 1982; 40(9):2003-10. PubMed ID: 6759712
    [No Abstract]   [Full Text] [Related]  

  • 25. The renin-angiotensin-aldosterone system: a pivotal role in insulin sensitivity and glycemic control.
    Perkins JM; Davis SN
    Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):147-52. PubMed ID: 18316950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene therapy for hypertension and restenosis.
    Gardon M; Raizada MK; Katovich MJ; Berecek KH; Gelband CH
    J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):211-6. PubMed ID: 11881028
    [No Abstract]   [Full Text] [Related]  

  • 27. The incidence and implications of aldosterone breakthrough.
    Bomback AS; Klemmer PJ
    Nat Clin Pract Nephrol; 2007 Sep; 3(9):486-92. PubMed ID: 17717561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aldosterone and vascular damage.
    Duprez D; De Buyzere M; Rietzschel ER; Clement DL
    Curr Hypertens Rep; 2000 Jun; 2(3):327-34. PubMed ID: 10981167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined renin-angiotensin-aldosterone system inhibition in patients with chronic heart failure secondary to left ventricular systolic dysfunction.
    Gradman AH; Papademetriou V
    Am Heart J; 2009 Jun; 157(6 Suppl):S17-23. PubMed ID: 19450720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker.
    Chrysostomou A; Pedagogos E; MacGregor L; Becker GJ
    Clin J Am Soc Nephrol; 2006 Mar; 1(2):256-62. PubMed ID: 17699214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blockade of renin-angiotensin-aldosterone system in kidney and heart disease: how much do we need?
    Lim S
    Acta Med Indones; 2008 Jan; 40(1):34-7. PubMed ID: 19054878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the renin-angiotensin system in vascular inflammation.
    Marchesi C; Paradis P; Schiffrin EL
    Trends Pharmacol Sci; 2008 Jul; 29(7):367-74. PubMed ID: 18579222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The neuroendocrine-immune interface gone awry in aldosteronism.
    Weber KT
    Cardiovasc Res; 2004 Dec; 64(3):381-3. PubMed ID: 15537489
    [No Abstract]   [Full Text] [Related]  

  • 34. Adipose cell-adrenal interactions: current knowledge and future perspectives.
    Ronconi V; Turchi F; Bujalska IJ; Giacchetti G; Boscaro M
    Trends Endocrinol Metab; 2008 Apr; 19(3):100-3. PubMed ID: 18299203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidative stress and profibrotic action of aldosterone.
    Caló LA; Pagnin E; Davis PA; Armanini D
    Am J Hypertens; 2005 Mar; 18(3):441. PubMed ID: 15797667
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hypertension in postmenopausal women --selected pathomechanisms].
    Pośnik-Urbańska A; Kawecka-Jaszcz K
    Przegl Lek; 2006; 63(12):1313-7. PubMed ID: 17642147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of central angiotensin in regulating cardiovascular activity].
    Zhu GQ; Wang W
    Sheng Li Ke Xue Jin Zhan; 2003 Oct; 34(4):343-6. PubMed ID: 14992019
    [No Abstract]   [Full Text] [Related]  

  • 38. Biology of cardiac failure.
    Harris P
    Eur Heart J; 1982 Dec; 3 Suppl D():5-10. PubMed ID: 6761127
    [No Abstract]   [Full Text] [Related]  

  • 39. Aldosterone and cardiovascular disease.
    Gaddam KK; Pimenta E; Husain S; Calhoun DA
    Curr Probl Cardiol; 2009 Feb; 34(2):51-84. PubMed ID: 19135616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is kidney ischemia the central mechanism in parallel activation of the renin and sympathetic system?
    Siddiqi L; Joles JA; Grassi G; Blankestijn PJ
    J Hypertens; 2009 Jul; 27(7):1341-9. PubMed ID: 19444143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.